I wonder if this could work for prostate cancer bone mets, including those who have already had chemo. Given they are using the same chemo commonly used in 1st line treatment for Stage 4 prostate cancer, what is the difference, if any, using this same chemo in nanoparticles, as discussed in the article below:
"....researchers developed a nanoparticle containing the chemotherapy Taxotere (docetaxel)..."
Researchers Develop New Strategy to Target Breast Cancer Metastasis in Bones
October 11, 2017 Alice Melãoby Alice Melão